The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.

The FDA approves leucovorin for a rare brain disorder while retreating from top officials’ earlier insistence that it could benefit many children with autism.

Washington — The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called cerebral folate deficiency, but not for children with the much ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump admin backs off claims synthetic vitamin could help autism Despite stating ...

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

Drug's approval expanded, but only to patients with genetic cerebral folate transport defi ...

Six months ago, the federal government loudly proclaimed the likely benefits of an existing drug called leucovorin for treating autism. Now that proclamation has officially turned into a whimper. On ...

The Trump administration appears to be walking back its statements from last year that the prescription drug leucovorin can be used to treat certain patients with autism. The Food and Drug ...

Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...